For research use only. Not for therapeutic Use.
JZP-430 is a potent, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) with an IC50 of 44 nM, exhibits ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL)[1].
| Catalog Number | I007469 |
| CAS Number | 1672691-74-5 |
| Synonyms | (4-morpholin-4-yl-1,2,5-thiadiazol-3-yl) N-cyclooctyl-N-methylcarbamate |
| Molecular Formula | C16H26N4O3S |
| Purity | ≥95% |
| InChI | InChI=1S/C16H26N4O3S/c1-19(13-7-5-3-2-4-6-8-13)16(21)23-15-14(17-24-18-15)20-9-11-22-12-10-20/h13H,2-12H2,1H3 |
| InChIKey | WKSHMJCYWFOADB-UHFFFAOYSA-N |
| SMILES | CN(C1CCCCCCC1)C(=O)OC2=NSN=C2N3CCOCC3 |
| Reference | [1]. Patel JZ, et al. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors. ChemMedChem. 2015 Feb;10(2):253-65. |
